Dr. Thames partners with Psych U and Otsuka Pharmaceuticals Development and Commercialization to address agitation in Alzheimer’s disease among disinvested communities

SNIHP

Dr. Thames is featured in an educational webinar to address inequalities in agitation among disinvested communities with Alzheimer’s disease.